TGFB1 and ductal breast carcinoma in situ: Pathways such as TGF-β or IL-8 regulate EMT and invasion (Bhowmick et al., 2001; Zhang et al., 2016), and may compensate for loss of CCR2 expression to sustain invasion in more tumorigenic cell lines, such as DCIS.com.